-- 週一上午晚些時候，美國存託憑證（ADR）開盤走低，歐洲股市在美國交易。標普歐洲精選ADR指數下跌0.70%，至1803.50點。 歐洲大陸方面，領漲的股票包括半導體公司Sequans Communications (SQNS)和生物製藥公司argenx (ARGX)，分別上漲8.1%和1.9%。緊隨其後的是石油煉製公司Equinor (EQNR)和生物製藥公司Grifols (GRFS)，分別上漲1.8%和1.5%。 歐洲大陸方面，領跌的股票包括製藥公司賽諾菲 (SNY)和銀行Banco Bilbao Vizcaya Argentaria (BBVA)，分別下跌5.5%和4.2%。緊隨其後的是醫療器材製造商EDAP TMS (EDAP)和生物製藥公司Cellectis (CLLS)，分別下跌3.3%和1%。 英國漲幅居前的股票包括生物製藥公司Akari Therapeutics (AKTX)和生技公司Autolus Therapeutics (AUTL)，分別上漲9.2%和2.8%。緊隨其後的是生物製藥公司Biodexa Pharmaceuticals (BDRX)和Amarin (AMRN)，分別上漲2.3%和2.2%。 英國和愛爾蘭跌幅居前的股票包括生物製藥公司NuCana (NCNA)和郵輪營運商Carnival (CUK)，分別下跌2.2%和1.6%。緊隨其後的是製藥公司葛蘭素史克 (GSK)和生技公司Trinity Biotech (TRIB)，分別下跌1.2%和0.4%。
Related Articles
Mining & Metals
Aya Gold & Silver Lists Its Shares on the Nasdaq Exchange
Aya Gold & Silver's (AYA.TO, AYA) on Monday said its shares are now trading on Nasdaq under the ticker symbol "AYA".With the start of trading on Nasdaq, the company's shares are no longer traded on the OTCQX market.The company's shares will continue to trade on the Toronto Stock Exchange under the symbol "AYA", it added."Access to the U.S. capital markets through Nasdaq is an exciting milestone for Aya as we close a record year and advance our growth strategy, supported by our attractive precious metals portfolio," said chief executive Benoit La Salle. "This listing is expected to increase the visibility of our shares and expand our shareholder base as we continue executing on our development plans."The company's shares were last seen down $1.31 to $23.75 on the Toronto Stock Exchange.Price: $23.73, Change: $-1.33, Percent Change: -5.31%
$AYA$AYA.TO
Australia
Sector Update: Consumer
Consumer stocks were lower Monday afternoon, with the State Street Consumer Staples Select Sector SPDR ETF (XLP) and the State Street Consumer Discretionary Select Sector SPDR ETF (XLY) each falling about 1%.In corporate news, GameStop (GME) has proposed to acquire eBay (EBAY) in a cash-and-stock deal worth about $55.5 billion. GameStop fell past 7%, and eBay jumped 5.4%.
$EBAY$GME
Research
Research Alert: CFRA Maintains Buy Opinion On Shares Of Vici Properties Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We decrease our target by $1 to $34, based on a P/FFO of 11.8x our 2026 estimate, in line with VICI's three-year average multiple (11.8x). We increase our 2026 FFO forecast by $0.06 to $2.89 and 2027's by $0.03 to $2.96. VICI has maintained strong investment momentum in the past two quarters, announcing over $1B new capital commitments in consecutive quarters for the first time. The One Beverly Hills project loan, now totaling $1.5B, provides exposure to an ultra-high-end consumer market in the non-gaming space. Management has now hedged the majority of interest rate risk through 2027 as it works to de-risk the balance sheet. After a down year in Las Vegas in 2025, our expectations are for stronger travel this year. We also note there are now two significant long-term growth drivers, with the A's new stadium opening in Las Vegas in 2028 and the potential for an NBA expansion team in 2029-2030 looking more favorable, per NBA commissioner Adam Silver.
$VICI